- Home
- UPXI vs SLXN Comparison
UPXI vs SLXN Comparison
Compare UPXI & SLXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UPXI
- SLXN
- Stock Information
- Founded
- UPXI 2018
- SLXN 2008
- Country
- UPXI United States
- SLXN Israel
- Employees
- UPXI N/A
- SLXN N/A
- Industry
- UPXI Medicinal Chemicals and Botanical Products
- SLXN
- Sector
- UPXI Health Care
- SLXN
- Exchange
- UPXI Nasdaq
- SLXN NYSE
- Market Cap
- UPXI 4.6M
- SLXN 4.3M
- IPO Year
- UPXI 2021
- SLXN N/A
- Fundamental
- Price
- UPXI $2.16
- SLXN $0.94
- Analyst Decision
- UPXI
- SLXN Strong Buy
- Analyst Count
- UPXI 0
- SLXN 1
- Target Price
- UPXI N/A
- SLXN $5.00
- AVG Volume (30 Days)
- UPXI 12.7K
- SLXN 955.8K
- Earning Date
- UPXI 05-07-2025
- SLXN 05-21-2025
- Dividend Yield
- UPXI N/A
- SLXN N/A
- EPS Growth
- UPXI N/A
- SLXN N/A
- EPS
- UPXI N/A
- SLXN N/A
- Revenue
- UPXI $18,625,089.00
- SLXN N/A
- Revenue This Year
- UPXI $299.03
- SLXN N/A
- Revenue Next Year
- UPXI N/A
- SLXN N/A
- P/E Ratio
- UPXI N/A
- SLXN N/A
- Revenue Growth
- UPXI 4.75
- SLXN N/A
- 52 Week Low
- UPXI $2.03
- SLXN $0.21
- 52 Week High
- UPXI $15.91
- SLXN $13.56
- Technical
- Relative Strength Index (RSI)
- UPXI 37.17
- SLXN N/A
- Support Level
- UPXI $2.03
- SLXN N/A
- Resistance Level
- UPXI $2.25
- SLXN N/A
- Average True Range (ATR)
- UPXI 0.14
- SLXN 0.00
- MACD
- UPXI 0.02
- SLXN 0.00
- Stochastic Oscillator
- UPXI 23.01
- SLXN 0.00
About UPXI Upexi Inc.
Upexi Inc specializes in the development, manufacturing, and distribution of consumer products. It reaches consumers through its direct-to-consumer network, wholesale partnerships, and prominent third-party platforms like Amazon.
About SLXN BIOMOTION SCIENCES
Silexion Therapeutics Corp is a developmental-stage company dedicated to the development of treatments for pancreatic cancer. The company is focused on enhancing its first-generation product (LODERTM ) to develop a newly formulated product to improve the clinical efficacy against pancreatic cancer.